|
gptkbp:instanceOf
|
biotechnology company
|
|
gptkbp:acquisition
|
gptkb:Zymeworks
gptkb:Ionis_Pharmaceuticals
|
|
gptkbp:awards
|
Best Places to Work
Scrip Awards
PharmaTimes Awards
Forbes_World's_Most_Innovative_Companies
Top_Employer_in_the_U.S.
|
|
gptkbp:CEO
|
gptkb:Michel_Vounatsos
|
|
gptkbp:clinicalTrials
|
Alzheimer's disease
multiple sclerosis
spinal muscular atrophy
|
|
gptkbp:collaborations
|
gptkb:Harvard_University
gptkb:Massachusetts_Institute_of_Technology
gptkb:University_of_California,_San_Francisco
|
|
gptkbp:communityEngagement
|
volunteer programs
STEM education initiatives
patient advocacy programs
environmental stewardship programs
healthcare_access_initiatives
|
|
gptkbp:employees
|
7,000 (2021)
|
|
gptkbp:founded
|
1978
|
|
gptkbp:founder
|
gptkb:M._A._(Marty)_Houghton
|
|
gptkbp:headCoach
|
Alfred_Sandrock
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
gptkb:United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Biogen
|
|
gptkbp:industry
|
biotechnology
|
|
gptkbp:market
|
$40 billion (2021)
|
|
gptkbp:notableFeature
|
gptkb:Tecfidera
gptkb:Plegridy
gptkb:Spinraza
gptkb:Avonex
gptkb:Tysabri
Aduhelm
Vumerity
|
|
gptkbp:partnerships
|
gptkb:Samsung_Bioepis
gptkb:Alnylam_Pharmaceuticals
|
|
gptkbp:philanthropy
|
gptkb:Biogen_Foundation
|
|
gptkbp:products
|
gptkb:Nusinersen
Aducanumab
|
|
gptkbp:researchFocus
|
neurological diseases
|
|
gptkbp:researchInterest
|
gptkb:Biogen_Research_Center
|
|
gptkbp:revenue
|
$11.4 billion (2020)
|
|
gptkbp:stockSymbol
|
gptkb:BIIB
|
|
gptkbp:subsidiary
|
gptkb:Biogen_Idec
|
|
gptkbp:sustainabilityInitiatives
|
Biogen's_Environmental_Sustainability_Program
|
|
gptkbp:tradedOn
|
gptkb:NASDAQ
|
|
gptkbp:website
|
www.biogen.com
|